Mary Mosher

Array ( [id] => 6638601 [patent_doc_number] => 20030211964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Method of inhibiting pathogenicity of infectious agents' [patent_app_type] => new [patent_app_number] => 10/321785 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 28099 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211964.pdf [firstpage_image] =>[orig_patent_app_number] => 10321785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7428519 [patent_doc_number] => 20040265986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Method for the recovery and purification of poxviruses from infected cells' [patent_app_type] => new [patent_app_number] => 10/495151 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6547 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265986.pdf [firstpage_image] =>[orig_patent_app_number] => 10495151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865751 [patent_doc_number] => 20030191277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Method for making insulin precursors and insulin precursor analogs' [patent_app_type] => new [patent_app_number] => 10/316421 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24103 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191277.pdf [firstpage_image] =>[orig_patent_app_number] => 10316421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697289 [patent_doc_number] => 20030109483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Use of Parapox B2L protein to treat cancer and modify immune responses' [patent_app_type] => new [patent_app_number] => 10/313332 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7013 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109483.pdf [firstpage_image] =>[orig_patent_app_number] => 10313332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668174 [patent_doc_number] => 07094412 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Poxvirus containing formulations and process for preparing stable poxvirus containing compositions' [patent_app_type] => utility [patent_app_number] => 10/496858 [patent_app_country] => US [patent_app_date] => 2002-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10286 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094412.pdf [firstpage_image] =>[orig_patent_app_number] => 10496858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1024382 [patent_doc_number] => 06884595 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-26 [patent_title] => 'Immortalized human keratinocyte cell line' [patent_app_type] => utility [patent_app_number] => 10/299938 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 15139 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884595.pdf [firstpage_image] =>[orig_patent_app_number] => 10299938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1024382 [patent_doc_number] => 06884595 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-26 [patent_title] => 'Immortalized human keratinocyte cell line' [patent_app_type] => utility [patent_app_number] => 10/299938 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 15139 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884595.pdf [firstpage_image] =>[orig_patent_app_number] => 10299938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740110 [patent_doc_number] => 20030157479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Antigen arrays for treatment of allergic eosinophilic diseases' [patent_app_type] => new [patent_app_number] => 10/289454 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 45312 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157479.pdf [firstpage_image] =>[orig_patent_app_number] => 10289454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 633856 [patent_doc_number] => 07128911 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-31 [patent_title] => 'Antigen arrays for treatment of bone disease' [patent_app_type] => utility [patent_app_number] => 10/289456 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 36709 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/128/07128911.pdf [firstpage_image] =>[orig_patent_app_number] => 10289456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1114821 [patent_doc_number] => 06800288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-05 [patent_title] => 'Recombinant influenza A viruses' [patent_app_type] => B2 [patent_app_number] => 10/204664 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 7896 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/800/06800288.pdf [firstpage_image] =>[orig_patent_app_number] => 10204664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 701137 [patent_doc_number] => 07063851 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-20 [patent_title] => 'Herpes viruses for immune modulation' [patent_app_type] => utility [patent_app_number] => 10/273348 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9059 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/063/07063851.pdf [firstpage_image] =>[orig_patent_app_number] => 10273348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 953824 [patent_doc_number] => 06958237 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-25 [patent_title] => 'Highly infectious rubella virus DNA constructs and methods of production' [patent_app_type] => utility [patent_app_number] => 10/271311 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 13342 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/958/06958237.pdf [firstpage_image] =>[orig_patent_app_number] => 10271311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706232 [patent_doc_number] => 20030152966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Chromatographic method for high yield purification and viral inactivation of antibodies' [patent_app_type] => new [patent_app_number] => 10/270918 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6319 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20030152966.pdf [firstpage_image] =>[orig_patent_app_number] => 10270918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851527 [patent_doc_number] => 20030143730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Method for producing recombinant adenovirus' [patent_app_type] => new [patent_app_number] => 10/267865 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13963 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143730.pdf [firstpage_image] =>[orig_patent_app_number] => 10267865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860584 [patent_doc_number] => 20030091592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Generation of virus-like particles by VSV' [patent_app_type] => new [patent_app_number] => 10/268133 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18564 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091592.pdf [firstpage_image] =>[orig_patent_app_number] => 10268133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 648691 [patent_doc_number] => 07115266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-03 [patent_title] => 'Angiotensin peptide-carrier conjugates and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/264267 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 29603 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115266.pdf [firstpage_image] =>[orig_patent_app_number] => 10264267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073607 [patent_doc_number] => 06838272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-04 [patent_title] => 'Filtration process for separating viruses' [patent_app_type] => utility [patent_app_number] => 10/255506 [patent_app_country] => US [patent_app_date] => 2002-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5819 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838272.pdf [firstpage_image] =>[orig_patent_app_number] => 10255506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813682 [patent_doc_number] => 20030073232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Methods and vector constructs useful for production of recombinant AAV' [patent_app_type] => new [patent_app_number] => 10/255527 [patent_app_country] => US [patent_app_date] => 2002-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6290 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073232.pdf [firstpage_image] =>[orig_patent_app_number] => 10255527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6642886 [patent_doc_number] => 20030103996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Cell-based vaccine' [patent_app_type] => new [patent_app_number] => 10/255423 [patent_app_country] => US [patent_app_date] => 2002-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7873 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20030103996.pdf [firstpage_image] =>[orig_patent_app_number] => 10255423 [rel_patent_id] =>[rel_patent_doc_number] =>)